Stay updated on SubQ Efgartigimod in CIDP Clinical Trial

Sign up to get notified when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Efgartigimod in CIDP Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    This page shows a minor site update: a new Revision: v3.3.2 was added and the previous Revision: v3.3.1 was removed. The change appears to affect only UI/versioning text and does not modify the study content, eligibility criteria, enrollment, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T14:18:51.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Publication notes now say PubMed publications are automatically filled and may not be about the study, alongside a new Revision: v3.3.1. The old PubMed text has been replaced with this updated note.
    Difference
    0.0%
    Check dated 2025-11-21T13:08:40.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added Tainan, Taiwan to the study locations; removed Tainan City, Taiwan from the locations list.
    Difference
    0.1%
    Check dated 2025-11-14T07:42:56.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots. The page content and layout appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-07T04:27:07.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Add: new operating-status notice and a new version tag v3.2.0. Delete: removal of a specific resource entry (Chronic inflammatory demyelinating polyradiculoneuropathy) and an older version tag v3.0.2. Overall, the page now signals current status and a more recent release, with a different resource mention.
    Difference
    2%
    Check dated 2025-10-02T08:08:15.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Removed four MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); overall breadth of content is reduced.
    Difference
    0.2%
    Check dated 2025-09-25T02:27:48.000Z thumbnail image

Stay in the know with updates to SubQ Efgartigimod in CIDP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.